Skip to main content
. 2015 Nov 23;7(1):565–579. doi: 10.18632/oncotarget.6376

Figure 3. Chk1 and TAZ are differentially modulated between non-small cell lung cancer cells with BRAF mutations (KIBRAF) and those with wild-type BRAF (WTBRAF).

Figure 3

A. Western blot analysis showing changes in protein expression for cells incubated with 150nM dasatinib for the indicated times. Bands were quantitated in the line graphs at the bottom. B. mRNA levels of Chk1 and TAZ were measured using quantitative polymerase chain reaction for the indicated times following incubation with 150nM dasatinib. C. mRNA levels of TAZ target genes were measured using quantitative polymerase chain reaction for the indicated times following incubation with 150nM dasatinib. Error bars represent standard deviation. *P < 0.05.